Clinical Trials Directory

Trials / Completed

CompletedNCT00710203

Dermatosis Papulosa Nigra

Efficacy of a 585 nm Pulsed Dye Laser (PDL) for the Treatment of Dermatosis Papulosa Nigra, and Compare it to Therapy With Curettage and Electrodesiccation.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

DPN is a disorder among darkly pigmented patients, manifested by small, benign, variants of seborrheic keratoses, predominantly on the face. The purpose of this study is to determine the efficacy of a 585 nm PDL for the treatment of Dermatosis Papulosa Nigra, and compare it to therapy with curettage (scraping the lesions off) and electrodesiccation (burning the lesions off).

Conditions

Interventions

TypeNameDescription
DEVICEPulsed dye laserOne lesion will be chosen for treatment with the pulsed dye laser with a 7 mm spot size. A single 10 J/cm2 pulse with 10 ms pulse duration will be used to treat the lesion.
PROCEDURECurettageA second lesion will be treated with curettage with or without anesthetic, depending on the patient's preference.
PROCEDUREElectrodesiccationA third lesion will be treated with electrodesiccation after infiltration of 1% lidocaine with epinephrine.
OTHERNo treatmentA fourth lesion will not be treated and will serve as a control.

Timeline

Start date
2008-07-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2008-07-04
Last updated
2015-04-28
Results posted
2014-03-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00710203. Inclusion in this directory is not an endorsement.